Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis

EMBO Journal

Volumn 20, Issue 6, 2001, Pages 1271-1280

  Kobayashi, Norihiko ^a   Kadono, Yuho ^b   Naito, Asuka ^c   Matsumoto, Kunihiro ^d   Yamamoto, Tadashi ^c   Tanaka, Sakae ^b   Inoue, Jun Ichiro ^e  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

^e KEIO UNIVERSITY   (Japan)

Author keywords

MAPK; NF B; Oteoclastogenesis; RANK; TRAF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; LIGAND; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR RECEPTOR; ZINC FINGER PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; ENZYME ACTIVATION; MALE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; SPLEEN CELL;

ANIMALS; BINDING SITES; BONE RESORPTION; CELL DIFFERENTIATION; ENZYME ACTIVATION; INTERLEUKIN-1; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MICE; MICE, MUTANT STRAINS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OSTEOCLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEINS; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 2; TNF RECEPTOR-ASSOCIATED FACTOR 5; TNF RECEPTOR-ASSOCIATED FACTOR 6; ZINC FINGERS;

ANIMALIA;

EID: 0035868884     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.6.1271     Document Type: Article

References (43)

1. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function
2. Tumor necrosis factor receptor-associated factors (TRAFs) - A family of adapter proteins that regulates life and death
3. Signaling by proinflammatory cytokines: Oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain
4. TRAF6 is a signal transducer for interleukin-1
5. Involvement of CRAF1, a relative of TRAF, in CD40 signaling
6. An intact zinc ring finger is required for tumor necrosis factor receptor-associated factor-mediated NF-κB activation but is dispensable for c-Jun N-terminal kinase signaling
7. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain
8. RANK is essential for osteoclast and lymph node development
9. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of αvβ3 integrin and phosphorylated by src kinase
10. Requirement for NF-κB in osteoclast and B-cell development
11. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-κB, a member of the TNFR superfamily
12. c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling
13. Osteopetrosis in mice lacking NF-κB1 and NF-κB2
14. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region
15. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling
16. Unresponsiveness of MyD88-deficient mice to endotoxin
17. Association of the p75 neurotrophin receptor with TRAF6
18. New experimental approaches in retrovirus-mediated expression screening
19. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
20. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway
21. TRAF6 deficiency results in osteopetrosis and defective intedeukin-1, CD40 and LPS signaling
22. Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts
23. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation
24. Mice lacking β3 integrins are osteosclerotic because of dysfunctional osteoclasts
25. Crystallographic analysis of CD40 recognition and signaling by human TRAF2
26. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice
27. TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-β receptor
28. Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation
29. The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway
30. ASK1 is essential for JNK/SAPK activation by TRAF2
31. Structural basis for self-association and receptor recognition of human TRAF2
32. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
33. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor
34. -/- mutant mice
35. NF-κB controls expression of inhibitor IκBα: Evidence for an inducible autoregulatory pathway
36. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway
37. Anatomy of TRAF2. Distinct domains for NF-κB activation and association with tumor necrosis factor signaling proteins
38. c-Cbl is downstream of c-Src in a Signalling pathway necessary for bone resorption
39. Bone resorption by osteoclasts
40. Two differently regulated NFκB activation pathways triggered by the cytoplasmic tail of CD40
41. The TRAF family of signal transducers mediates NF-κB activation by the TRANCE receptor
42. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src
43. Early lethality, functional NF-κB activation and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice